Amniotic and placental membranes.
The portfolio distinguishes single-layer amnion, dual-layer amnion, and configurations that include chorion or an intermediate layer. Names such as full-thickness or triple-layer describe construction.
Processing and hydration state also differ. Read the complete product identity and instructions rather than assuming that membranes with matching dimensions can be substituted.
Synthetic matrices.
The listed Microlyte profiles describe synthetic polymer matrices. The SAM record contains silver; PainGuard includes silver and lidocaine HCl.
A formulation difference can affect the relevant labeling, warnings, and staff review. Use the product-specific file and exact item code, not a general family brochure alone.
Collagen sheets and powders.
APIS and ECM3 illustrate why the collagen category needs more detail. APIS includes a porcine collagen derivative, Manuka honey, and hydroxyapatite. ECM3 is described as bovine collagen in sheet and powder formats.
Source species, composition, physical presentation, and complete labeling belong together. A powder mass should not be compared directly with a sheet area.
Autologous and device-based systems.
ActiGraft PRO is a point-of-care system using the individual's own whole blood. XSONX is a reusable handpiece with disposable heads. Neither is simply another membrane size.
Review components, consumable quantities, staff preparation, maintenance where applicable, and current system instructions. Keep unit quantities separate from box quantities.
Ocular disc formats.
The ocular membrane profile lists disc diameters in millimeters. These are different physical specifications from rectangular wound-care sheet dimensions in centimeters.
Use ocular-specific instructions and the exact RL item identifier. Shared tissue terminology does not make ocular and wound-care preparation instructions interchangeable.
Keep the decisions separate.
Material and format help organize a product review. They do not determine patient suitability, permitted use, coverage, or payment. The responsible clinical team evaluates the current product-specific labeling and evidence.